• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Home > News

DNDi and Rotary collaborate to prevent and treat diseases affecting neglected communities in Eastern Africa

Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor shaking hands
Prof. Sam Kariuki, DNDi Eastern Africa Director and Leonard Ithau, Rotary International District 9212 District Governor
29 Aug 2023

On 29 August 2023, Rotary Kenya and the non-profit medical research organization Drugs for Neglected Diseases initiative (DNDi) signed a five-year agreement to collaborate on research and access activities that support the health needs of neglected patients and communities.  

During the signing of the Memorandum of Understanding (MoU) held at the DNDi offices in Nairobi, Prof. Samuel Kariuki, the Eastern Africa Director, outlined the collaboration areas and their significance for Kenyan communities. 

‘This MoU is a great step forward in working together to reach grassroots communities as we raise awareness of the discovery and delivery of life-saving treatments for neglected populations. The synergy between DNDi and Rotary will empower communities through various activities, such as education campaigns on NTDs and other diseases, medical camps, and fundraising, among others,’ said Prof. Kariuki.  

Rotary Kenya, which operates in Kenya, Ethiopia, South Sudan, and Eritrea, is a constituent of Rotary District 9212 and part of Rotary International, a global non-profit service organization founded in 1905. They focus on seven areas of operation, including disease prevention, environmental conservation, and climate change, all of which have a significant connection to the diseases that DNDi seeks to address. 

2 people sign documents while 5 people stand behind them
Leonard Ithau, Rotary District 9212 Governor and Prof. Sam Kariuki, Eastern Africa Director, DNDi signing copies of the MoU. Looking on is Wairimu Njagi, District Governor Nominee; Dr Joe Kamau, District Governor Elect at Rotary District 9212; Simon Bolo, Head of Leishmaniasis Access, DNDi; and Lydia Manoti, Philanthropy Manager, DNDi.

‘Rotary Kenya and DNDi share some common goals. It is important that we explore partnerships to tackle the complex issues that communities face, create positive impact in the communities of operations, and serve their needs,’ said Leonard Ithau, Governor, Rotary District 9212.  

The main areas of cooperation will include: 

  • Creating awareness of neglected diseases through communication and information dissemination to the public and community leaders.  
  • Reinforcing and building on existing clinical capacities and addressing site infrastructure needs where necessary.  
  • Providing on-site training in clinical research and engaging in knowledge and skills sharing in the field of pharmaceutical R&D. 
  • Engaging in joint fundraising efforts for the benefit of neglected patients.  
  • Fostering deeper engagement between neglected disease experts and grassroots communities in Eastern Africa. 

Through this collaboration, Rotary Kenya and DNDi hope to make a significant difference in preventing and treating neglected tropical diseases by accelerating the development of new medicines and improving access to safe and effective treatments in the region. 

Group of people stand behind a table
From left to right: Joy Malongo, Access Manager, DNDi; Cherinet Adera, Senior Market Access Manager, DNDi; Wairimu Njagi, District Governor Nominee, Rotary; Linet Otieno, Head of Communications, DNDi; Dr Joe Kamau, District Governor Elect at Rotary District 9212; Leonard Ithau, Rotary District 9212 Governor; Prof. Sam Kariuki, Eastern Africa Director, DNDi; Simon Bolo, Head of Leishmaniasis Access, DNDi; Saum Siraj, Vice Chair, Community Services District 9212; Beryl Anyango, Executive Office Associate, DNDi; and Lydia Manoti, Philanthropy Manager, DNDi.
Partnership Strengthening Capacities Africa

Read, watch, share

Loading...
Press releases
27 Jul 2026

DNDi leadership to change in 2027

Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

Publications
16 Jul 2026

DNDi 2025 Annual Report

Laboratory of Medicinal and Computational Chemistry (LQMC), São Paulo University USP, São Carlos Campus, São Paulo Brazil.
Press releases
13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security 

Chepokarial Rubben attentively cares for her five-year-old son, Romanu Kiptoo, at the kala-azar ward of Kacheliba Sub-County Referral Hospital in West Pokot County, Kenya. She gently soothes him, offering comfort as he endures the painful treatment for kala-azar.
Press releases
13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Press releases
8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Patricia, 44, from Area 44 in Lilongwe, Malawi, has lived with vision loss for 10 years following a late diagnosis of cryptococcal meningitis.
Stories
30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

News
29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors 

VIEW ALL

Help neglected patients

To date, we have delivered fourteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube X-twitter Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license